SEK257.20
1.68% today
Stockholm, Jun 13, 11:02 am CET
ISIN
SE0009858152
Symbol
BONEX
Sector

Bonesupport Holding AB Stock price

SEK261.60
-33.40 11.32% 1M
-83.80 24.26% 6M
-125.20 32.37% YTD
+0.00 0.00% 1Y
+223.40 584.82% 5Y
+229.60 717.50% 10Y
+229.60 717.50% 20Y
Stockholm, Closing price Thu, Jun 12 2025
-3.20 1.21%
ISIN
SE0009858152
Symbol
BONEX
Sector

Key metrics

Market capitalization SEK17.44b
Enterprise Value SEK17.19b
P/E (TTM) P/E ratio 141.41
EV/FCF (TTM) EV/FCF 189.30
EV/Sales (TTM) EV/Sales 17.22
P/S ratio (TTM) P/S ratio 17.48
P/B ratio (TTM) P/B ratio 23.58
Revenue growth (TTM) Revenue growth 52.17%
Revenue (TTM) Revenue SEK997.85m
EBIT (operating result TTM) EBIT SEK163.51m
Free Cash Flow (TTM) Free Cash Flow SEK90.78m
Cash position SEK267.14m
EPS (TTM) EPS SEK1.85
P/E forward 78.15
P/S forward 13.77
EV/Sales forward 13.57
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Bonesupport Holding AB forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Bonesupport Holding AB forecast:

Buy
75%
Hold
25%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
998 998
52% 52%
100%
- Direct Costs 74 74
41% 41%
7%
924 924
53% 53%
93%
- Selling and Administrative Expenses 657 657
32% 32%
66%
- Research and Development Expense 86 86
46% 46%
9%
170 170
204% 204%
17%
- Depreciation and Amortization 6.89 6.89
35% 35%
1%
EBIT (Operating Income) EBIT 164 164
260% 260%
16%
Net Profit 122 122
54% 54%
12%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Mr. Billback
Employees 140
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today